Lung cancer: intragenic ERBB2 kinase mutations in tumours.
摘要:
The protein-kinase family is the most frequently mutated gene family found in human cancer and faulty kinase enzymes are being investigated as promising targets for the design of antitumour therapies. We have sequenced the gene encoding the transmembrane protein tyrosine kinase ERBB2 (also known as HER2 or Neu) from 120 primary lung tumours and identified 4% that have mutations within the kinase domain; in the adenocarcinoma subtype of lung cancer, 10% of cases had mutations. ERBB2 inhibitors, which have so far proved to be ineffective in treating lung cancer, should now be clinically re-evaluated in the specific subset of patients with lung cancer whose tumours carry ERBB2 mutations.
展开
关键词:
Humans Carcinoma, Non-Small-Cell Lung Lung Neoplasms Quinazolines Receptor, Epidermal Growth Factor Receptor, erbB-2 DNA Mutational Analysis Protein Structure, Tertiary Mutation Neoplasms
DOI:
10.1038/431525b
被引量:
年份:
2004









































通过文献互助平台发起求助,成功后即可免费获取论文全文。
相似文献
参考文献
引证文献
辅助模式
引用
文献可以批量引用啦~
欢迎点我试用!